Search Within

Diana E Lake

Formats
  1. Meeting Abstract (48)
  2. Journal Article (39)
  3. Book Whole (1)
  4. Editorial (1)
Groups
  1. Breast Medicine Service (89)
  2. Department of Medicine (89)
  3. Solid Tumor Oncology Division (89)
  4. Survivorship Research (89)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (55)
  6. Epidemiology and Biostatistics (48)

More Groups

People
  1. Clifford Hudis (65)
  2. Larry Norton (45)
  3. Gabriella D'Andrea-Carlino (39)
  4. Chau Dang (37)
  5. Monica Fornier (36)
  6. Maura Dickler (33)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (1)
  4. 2022 (4)
  5. 2021 (1)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (30)
  2. Cancer Research (16)
  3. Breast Cancer Research and Treatment (13)
  4. Clinical Breast Cancer (7)
  5. Clinical Cancer Research (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. American Association for Cancer Research (20)
  3. Springer (14)
  4. Elsevier Inc. (9)
  5. Oxford University Press (3)
  6. American Medical Association (2)

More Publishers

Results (89)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane
    Journal Article

    Modi, S.; Currie, V. E.; Seidman, A. D.; Bach, A. M.; Panageas, K. S.; Theodoulou, M.; Moasser, M. M.; D'Andrea, G. M.; Lake, D. E.; Choi, J.; more...
    Clinical Breast Cancer (2005)

    Fulltext@MSK | Save
  • High-dose chemotherapy in breast cancer
    Journal Article

    Lake, D. E.; Hudis, C. A.
    Drugs (2004)

    Fulltext@MSK | Save
  • Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer: CALGB 9332
    Journal Article

    Johnson, E.; Lake, D.; Herndon, J. E. 2nd; Box, J. W.; Lynch, T. J.; Green, M. R.
    American Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer
    Journal Article

    Dang, C. T.; D'Andrea, G. M.; Moynahan, M. E.; Dickler, M. N.; Seidman, A. D.; Fornier, M.; Robson, M. E.; Theodoulou, M.; Lake, D.; Currie, V. E.; more...
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save
  • Aromatase inhibitors in breast cancer: An update
    Journal Article

    Lake, D. E.; Hudis, C.
    Cancer Control (2002)

    Fulltext@MSK | Save
  • Combined estrogen blockade of the breast with raloxifene and exemestane in postmenopausal women for breast cancer prevention
    Meeting Abstract

    Dickler, M. N.; Robson, M. E.; Heerdt, A.; Dang, C.; Lake, D.; Moasser, M.; Bloch, R.; Ballon, D. J.; Morris, E. A.; Tan, L. K.; more...
    Breast Cancer Research and Treatment (2001)

    Fulltext@MSK | Save
  • Oncologic emergencies: Introduction
    Journal Article

    Lake, D. E.; Hudis, C.
    Seminars in Oncology (2000)

    Fulltext@MSK | Save
  • A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: Cancer and Leukemia Group B study 9181
    Journal Article

    Dawson, N. A.; Conaway, M.; Halabi, S.; Winer, E. P.; Small, E. J.; Lake, D.; Vogelzang, N. J.
    Cancer (2000)

    Fulltext@MSK | Save
  • Phase II study of PSC 833 (PSC) and vad chemotherapy in patients with VAD-refractory multiple myeloma (MM)
    Meeting Abstract

    Case, D. C.; Jain, V.; Stiff, P.; Jansen, J.; Stewart, A. K.; Shurafa, M.; Hussein, M.; Heffner, L. T.; Irwin, D.; Greipp, P.; more...
    Blood (1998)

    Fulltext@MSK | Save